LANE ENDS SURGERY
200 TULKETH BROW, ASHTON-ON-RIBBLE, PRESTONCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 30 | 33 | 90.9% | |
CKD 4 | 2008 | 119 | 145 | 82.1% | |
CKD 5 | 2009 | 43 | 50 | 86.0% | |
CKD 5 | 2010 | 10 | 13 | 76.9% | |
CKD 5 | 2011 | 16 | 19 | 84.2% | |
CKD 5 | 2012 | 14 | 16 | 87.5% | |
CKD 5 | 2013 | 16 | 18 | 88.9% | |
CKD003 | 2014 | 16 | 19 | 84.2% | |
CKD003 | 2015 | 14 | 18 | 77.8% | |
NM84 | 2016 | 16 | 23 | 69.6% | |
NM84 | 2018 | 29 | 38 | 76.3% | |
NM84 | 2022 | 35 | 46 | 76.1% | |
NM84 | 2023 | 27 | 40 | 67.5% |